ReviewFrontiers in oncology2022
Effects of N
Yong-Fu Zhu, Shu-Jie Wang, Jie Zhou, Ye-Han Sun, You-Mou Chen, Jia Ma, Xing-Xing Huo, Hang Song
Open access · goldAbstract readReview
In one paragraphReview in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 95% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors at 3 institutions in 1 country.
Yong-Fu ZhuThe First Department of Oncology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Shu-Jie WangAnhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, China.
Jie ZhouThe Department of Acupuncture, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Ye-Han SunThe First Department of Oncology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
You-Mou ChenThe First Department of Oncology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Jia MaThe First Department of Oncology, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Xing-Xing HuoExperimental Center of Clinical Research, Scientific Research Department, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Hang SongDepartment of Biochemistry and Molecular Biology, School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China.
Anhui University of Traditional Chinese Medicine · CNChinese Academy of Sciences · CNThe Third Affiliated Hospital of Zhejiang Chinese Medical University · CN
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Indexed as
female malignanciesimmunotherapymolecular mechanismsN6-methyladenosineRNA modifications
Identifiers
PMID35707365
PMCPMC9189310
OpenAlexW4281723772
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390